Skip to main content
Erschienen in: Breast Cancer 5/2023

12.06.2023 | Original Article

What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?

verfasst von: Sara van Bekkum, Marloes E. Clarijs, Fientje J. C. van der Veen, Joost van Rosmalen, Linetta B. Koppert, Marian B. E. Menke-Pluijmers

Erschienen in: Breast Cancer | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To establish the breast reconstruction rate in a large Dutch teaching hospital, and to gain insight into the motives of women to opt for or reject post-mastectomy breast reconstruction.

Methods

In a retrospective, cross-sectional study, all consecutive patients who underwent mastectomy for invasive breast cancer or ductal carcinoma in situ (DCIS) were identified and categorized into two groups based on subsequent breast reconstruction or not. Patient-reported outcomes were assessed with the validated Breast-Q and a short survey about the decision-making process in breast reconstruction. These outcomes were compared between the two groups using univariable analyses, multivariable logistic regression, and multiple linear regression analyses. The Breast-Q scores were also compared to Dutch normative values.

Results

A total of 319 patients were identified of whom 68% had no breast reconstruction. Of the 102 patients with breast reconstruction, the majority (93%) received immediate, instead of delayed breast reconstruction. The survey was completed by 155 (49%) patients. The non-reconstruction group, on average, reported significantly poorer psychosocial well-being, compared to the reconstruction group as well as compared to the normative data. However, the majority of the non-reconstruction group (83%) stated that they had no desire for breast reconstruction. In both groups, most patients stated that the provided information was sufficient.

Conclusion

Patients have personal motives to opt for or reject breast reconstruction. It seemed that patients differ in their rating of values that affect their decision since the same arguments were used to opt for or reject reconstruction. Notably, patients were well-informed in their decision making.
Literatur
1.
Zurück zum Zitat Howard-McNatt MM. Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefit. Breast Cancer Targets Ther. 2013;5:9–15. Howard-McNatt MM. Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefit. Breast Cancer Targets Ther. 2013;5:9–15.
3.
Zurück zum Zitat van Maaren MC, de Munck L, de Bock GH, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17(8):1158–70. CrossRefPubMed van Maaren MC, de Munck L, de Bock GH, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17(8):1158–70. CrossRefPubMed
4.
Zurück zum Zitat Winters ZE, Benson JR, Pusic AL. A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient-reported outcome measures and health-related quality of life. Ann Surg. 2010;252(6):929–42. CrossRefPubMed Winters ZE, Benson JR, Pusic AL. A systematic review of the clinical evidence to guide treatment recommendations in breast reconstruction based on patient-reported outcome measures and health-related quality of life. Ann Surg. 2010;252(6):929–42. CrossRefPubMed
5.
Zurück zum Zitat Lagendijk M, van Egdom LSE, van Veen FEE, et al. Patient-reported outcome measures may add value in breast cancer surgery. Ann Surg Oncol. 2018;25:3563–71.CrossRefPubMed Lagendijk M, van Egdom LSE, van Veen FEE, et al. Patient-reported outcome measures may add value in breast cancer surgery. Ann Surg Oncol. 2018;25:3563–71.CrossRefPubMed
6.
Zurück zum Zitat van Bommel ACM, Mureau MAM, Schreuder K, et al. Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands. J Plast Reconstr Aesthetic Surg. 2017;70:215–21.CrossRef van Bommel ACM, Mureau MAM, Schreuder K, et al. Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands. J Plast Reconstr Aesthetic Surg. 2017;70:215–21.CrossRef
8.
Zurück zum Zitat Fang SY, Shu BC, Chang YJ. The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis. Breast Cancer Res Treat. 2013;137(1):13–21.CrossRefPubMed Fang SY, Shu BC, Chang YJ. The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis. Breast Cancer Res Treat. 2013;137(1):13–21.CrossRefPubMed
9.
Zurück zum Zitat Retrouvey H, Kerrebijn I, Metcalfe KA, et al. Psychosocial functioning in women with early breast cancer treated with breast surgery with or without immediate breast reconstruction. Ann Surg Oncol. 2019;26:2444–51.CrossRefPubMed Retrouvey H, Kerrebijn I, Metcalfe KA, et al. Psychosocial functioning in women with early breast cancer treated with breast surgery with or without immediate breast reconstruction. Ann Surg Oncol. 2019;26:2444–51.CrossRefPubMed
10.
Zurück zum Zitat D’Souza N, Darmanin G, Fedorowicz Z. Immediate versus delayed reconstruction following surgery for breast cancer. Cochrane Database Syst Rev. 2011;2011(7):CD008674. D’Souza N, Darmanin G, Fedorowicz Z. Immediate versus delayed reconstruction following surgery for breast cancer. Cochrane Database Syst Rev. 2011;2011(7):CD008674.
11.
Zurück zum Zitat van Bommel ACM, de Ligt KM, Schreuder K, et al. The added value of immediate breast reconstruction to health-related quality of life of breast cancer patients. Eur J Surg Oncol. 2020;46(10):1848–53.CrossRefPubMed van Bommel ACM, de Ligt KM, Schreuder K, et al. The added value of immediate breast reconstruction to health-related quality of life of breast cancer patients. Eur J Surg Oncol. 2020;46(10):1848–53.CrossRefPubMed
12.
Zurück zum Zitat Kouwenberg CAE, De Ligt KM, Kranenburg LW, et al. Long-term health-related quality of life after four common surgical treatment options for breast cancer and the effect of complications: a retrospective patient-reported survey among 1871 patients. Plast Reconstr Surg. 2020;146(1):1–13.CrossRefPubMed Kouwenberg CAE, De Ligt KM, Kranenburg LW, et al. Long-term health-related quality of life after four common surgical treatment options for breast cancer and the effect of complications: a retrospective patient-reported survey among 1871 patients. Plast Reconstr Surg. 2020;146(1):1–13.CrossRefPubMed
14.
Zurück zum Zitat de Ligt KM, van Bommel ACM, Schreuder K, et al. The effect of being informed on receiving immediate breast reconstruction in breast cancer patients. Eur J Surg Oncol. 2018;44(5):717–24.CrossRefPubMed de Ligt KM, van Bommel ACM, Schreuder K, et al. The effect of being informed on receiving immediate breast reconstruction in breast cancer patients. Eur J Surg Oncol. 2018;44(5):717–24.CrossRefPubMed
15.
Zurück zum Zitat Flitcroft K, Brennan M, Spillane A. Making decisions about breast reconstruction: a systematic review of patient-reported factors influencing choice. Qual Life Res. 2017;26:2287–319.CrossRefPubMed Flitcroft K, Brennan M, Spillane A. Making decisions about breast reconstruction: a systematic review of patient-reported factors influencing choice. Qual Life Res. 2017;26:2287–319.CrossRefPubMed
16.
Zurück zum Zitat van Bommel A, Spronk P, Mureau M, et al. Breast-contour-preserving procedure as a multidisciplinary parameter of esthetic outcome in breast cancer treatment in the Netherlands. Ann Surg Oncol. 2019;26:1704–11.CrossRefPubMedPubMedCentral van Bommel A, Spronk P, Mureau M, et al. Breast-contour-preserving procedure as a multidisciplinary parameter of esthetic outcome in breast cancer treatment in the Netherlands. Ann Surg Oncol. 2019;26:1704–11.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Zielinski T, Lorenc-Podgorska K, Antoszewski B, Why women who have mastectomy decide not to have breast reconstruction? Pol Przegl Chir. 2014;86(10):451–5. Zielinski T, Lorenc-Podgorska K, Antoszewski B, Why women who have mastectomy decide not to have breast reconstruction? Pol Przegl Chir. 2014;86(10):451–5.
18.
Zurück zum Zitat Héquet D, Zarca K, Dolbeault S, et al. Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy. Springerplus. 2013;2:325. Héquet D, Zarca K, Dolbeault S, et al. Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy. Springerplus. 2013;2:325.
19.
Zurück zum Zitat Handel N, Silverstein MJ, Waisman E, Waisman JR. Reasons why mastectomy patients do not have breast reconstruction. Plast Reconstr Surg. 1990;86(6):1118–22.CrossRefPubMed Handel N, Silverstein MJ, Waisman E, Waisman JR. Reasons why mastectomy patients do not have breast reconstruction. Plast Reconstr Surg. 1990;86(6):1118–22.CrossRefPubMed
20.
Zurück zum Zitat Ananian P, Houvenaeghel G, Protière C, et al. Determinants of patients’ choice of reconstruction with mastectomy for primary breast cancer. Ann Surg Oncol. 2004;11(8):762–71.CrossRefPubMed Ananian P, Houvenaeghel G, Protière C, et al. Determinants of patients’ choice of reconstruction with mastectomy for primary breast cancer. Ann Surg Oncol. 2004;11(8):762–71.CrossRefPubMed
21.
Zurück zum Zitat Brennan ME, Spillane AJ. Uptake and predictors of post-mastectomy reconstruction in women with breast malignancy—systematic review. Eur J Surg Oncol. 2013;39(6):527–41.CrossRefPubMed Brennan ME, Spillane AJ. Uptake and predictors of post-mastectomy reconstruction in women with breast malignancy—systematic review. Eur J Surg Oncol. 2013;39(6):527–41.CrossRefPubMed
23.
Zurück zum Zitat Cano SJ, Klassen AF, Scott AM, Cordeiro PG, Pusic AL. The BREAST-Q: further validation in independent clinical samples. Plast Reconstr Surg. 2012;129(2):293–302.CrossRefPubMed Cano SJ, Klassen AF, Scott AM, Cordeiro PG, Pusic AL. The BREAST-Q: further validation in independent clinical samples. Plast Reconstr Surg. 2012;129(2):293–302.CrossRefPubMed
24.
Zurück zum Zitat Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;142(2):345–53.CrossRef Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;142(2):345–53.CrossRef
25.
Zurück zum Zitat Metcalfe KA, Semple J, Quan ML, et al. Why some mastectomy patients Opt to undergo delayed breast reconstruction: results of a long-term prospective study. Plast Reconstr Surg. 2017;139(2):267–75.CrossRefPubMed Metcalfe KA, Semple J, Quan ML, et al. Why some mastectomy patients Opt to undergo delayed breast reconstruction: results of a long-term prospective study. Plast Reconstr Surg. 2017;139(2):267–75.CrossRefPubMed
26.
Zurück zum Zitat Molenaar S, Oort F, Sprangers M, et al. Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study. Br J Cancer. 2004;90(11):2123–30.CrossRefPubMedPubMedCentral Molenaar S, Oort F, Sprangers M, et al. Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study. Br J Cancer. 2004;90(11):2123–30.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Oemrawsingh A, Clarijs M, Pusic A, et al. BREAST-Q breast-conserving therapy module: normative data from a Dutch sample of 9059 women. Plast Reconstr Surg. 2022;150(5):985–93.CrossRefPubMedPubMedCentral Oemrawsingh A, Clarijs M, Pusic A, et al. BREAST-Q breast-conserving therapy module: normative data from a Dutch sample of 9059 women. Plast Reconstr Surg. 2022;150(5):985–93.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Yoon AP, Qi J, Brown DL, et al. Outcomes of immediate versus delayed breast reconstruction: results of a multicenter prospective study. Breast. 2018;37:72–9.CrossRefPubMed Yoon AP, Qi J, Brown DL, et al. Outcomes of immediate versus delayed breast reconstruction: results of a multicenter prospective study. Breast. 2018;37:72–9.CrossRefPubMed
30.
Zurück zum Zitat Ricci JA, Epstein S, Momoh AO, Lin SJ, Singhal D, Lee BT. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. J Surg Res. 2017;218:108–16.CrossRefPubMed Ricci JA, Epstein S, Momoh AO, Lin SJ, Singhal D, Lee BT. A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy. J Surg Res. 2017;218:108–16.CrossRefPubMed
31.
Zurück zum Zitat Lam TC, Hsieh F, Boyages J. The effects of postmastectomy adjuvant radiotherapy on immediate two-stage prosthetic breast reconstruction: a systematic review. Plast Reconstr Surg. 2013;132:511–8.CrossRefPubMed Lam TC, Hsieh F, Boyages J. The effects of postmastectomy adjuvant radiotherapy on immediate two-stage prosthetic breast reconstruction: a systematic review. Plast Reconstr Surg. 2013;132:511–8.CrossRefPubMed
Metadaten
Titel
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?
verfasst von
Sara van Bekkum
Marloes E. Clarijs
Fientje J. C. van der Veen
Joost van Rosmalen
Linetta B. Koppert
Marian B. E. Menke-Pluijmers
Publikationsdatum
12.06.2023
Verlag
Springer Nature Singapore
Erschienen in
Breast Cancer / Ausgabe 5/2023
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-023-01471-4

Weitere Artikel der Ausgabe 5/2023

Breast Cancer 5/2023 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.